Pneumococcal genetic variability in age-dependent bacterial carriage

  1. Philip HC Kremer  Is a corresponding author
  2. Bart Ferwerda
  3. Hester J Bootsma
  4. Nienke Y Rots
  5. Alienke J Wijmenga-Monsuur
  6. Elisabeth AM Sanders
  7. Krzysztof Trzciński
  8. Anne L Wyllie
  9. Paul Turner
  10. Arie van der Ende
  11. Matthijs C Brouwer
  12. Stephen D Bentley
  13. Diederik van de Beek
  14. John Lees
  1. Amsterdam UMC, University of Amsterdam, Netherlands
  2. National Institute for Public Health and the Environment, Netherlands
  3. Wilhelmina Children's Hospital, Netherlands
  4. Yale School of Public Health, United States
  5. Angkor Hospital for Children, Cambodia
  6. Amsterdam UMC, Netherlands
  7. Wellcome Sanger Institute, United Kingdom
  8. European Bioinformatics Institute, United Kingdom

Abstract

The characteristics of pneumococcal carriage vary between infants and adults, with onward implications for transmission rates, and disease control using vaccines. Host immune factors have been shown to contribute to these age-specific differences, but the role of pathogen variation is currently less well-known. Indeed, identification of specific pneumococcal genetic factors associated with carriage in younger or older age groups may suggest alternative vaccine formulations would reduce overall disease. To search for such factors, we used whole genome sequencing to understand how pneumococcal variation is associated with age. We performed genome sequencing in a large carriage cohort, and conducted a meta-analysis with an existing carriage study. We compiled a dictionary of pathogen genetic variation including serotype, sequence cluster, sequence elements, SNPs, burden combined rare variants, and clusters of orthologous genes (COGs) for each cohort - all of which used in a genome-wide association with host age. Age-dependent colonization showed weak evidence for heritability in the first cohort (h2 = 0.10, 0.00 - 0.69 95% CI), and stronger evidence in the second cohort (h2 = 0.56, 0.23 - 0.87 95% CI). We found that serotypes and genetic background (strain) explained a proportion of the heritability in the first cohort (h2serotype = 0.07, 0.04 - 0.14 95% CI and h2GPSC = 0.06, 0.03 - 0.13 95% CI) and the second cohort (h2serotype = 0.11, 0.05 - 0.21 95% CI and h2GPSC = 0.20, 0.12 - 0.31 95% CI). In a meta-analysis of these cohorts, we found one candidate association (p = 1.2x10-9) upstream of an accessory Sec-dependent serine-rich glycoprotein adhesin. Overall, while we did find an effect of pathogen genome variation on pneumococcal carriage in children versus adult hosts, this was variable between populations and does not appear have a strong relationship with individual genes. This supports proposals for adaptive future vaccination strategies which are primarily targeted at dominant circulating serotypes, and tailored to the composition of the pathogen populations.

Data availability

Fastq sequences of bacterial isolates from the Dutch cohort were deposited in the European Nucleotide Archive (ENA, study and accession numbers in Supplementary Table S2). Sequences of bacterial isolates in the Maela cohort are available at ENA under study numbers ERP000435, ERP000483, ERP000485, ERP000487, ERP000598 and ERP000599 (Supplementary Table S3). Summary statistics for the results from the genome wide association studies can be found at https://figshare.com/articles/dataset/S_pneumoniae_carriage_GWAS/14431313

The following data sets were generated

Article and author information

Author details

  1. Philip HC Kremer

    Department of Neurology, Amsterdam UMC, University of Amsterdam, Meibergdreef, Netherlands
    For correspondence
    philip_kremer@hotmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0483-841X
  2. Bart Ferwerda

    Department of Neurology, Amsterdam UMC, University of Amsterdam, Meibergdreef, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  3. Hester J Bootsma

    Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  4. Nienke Y Rots

    Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  5. Alienke J Wijmenga-Monsuur

    Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5663-860X
  6. Elisabeth AM Sanders

    Department of Pediatric Immunology and Infectious D, Wilhelmina Children's Hospital, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  7. Krzysztof Trzciński

    Department of Pediatric Immunology and Infectious D, Wilhelmina Children's Hospital, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  8. Anne L Wyllie

    Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6015-0279
  9. Paul Turner

    Cambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, Cambodia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1013-7815
  10. Arie van der Ende

    Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  11. Matthijs C Brouwer

    Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  12. Stephen D Bentley

    Wellcome Sanger Institute, Hinxton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Diederik van de Beek

    Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  14. John Lees

    European Bioinformatics Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

Funding

European Research Council (281156)

  • Diederik van de Beek

ZonMw (91819627)

  • Diederik van de Beek

Wellcome Trust (219699)

  • John Lees

Wellcome Trust (083735/Z/07/Z)

  • Paul Turner

Rijksinstituut voor Volksgezondheid en Milieu

  • Arie van der Ende

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Bavesh D Kana, University of the Witwatersrand, South Africa

Ethics

Human subjects: in children and their parents (NL24116 and NL40288/NTR3613) were received from the National Ethics Committee in the Netherlands (CCMO and METC Noord-Holland). For the 2010/2011 study, a National Ethics Committee in The Netherlands (STEG-METC, Almere) waived the requirement for EC approval. Informed consent for the Maela cohort was described elsewhere.(6) Studies were conducted in accordance with the European Statements for Good Clinical Practice and the Declaration of Helsinki of the World Medical Association.

Version history

  1. Preprint posted: March 3, 2021 (view preprint)
  2. Received: April 8, 2021
  3. Accepted: July 3, 2022
  4. Accepted Manuscript published: July 26, 2022 (version 1)
  5. Version of Record published: August 22, 2022 (version 2)
  6. Version of Record updated: December 16, 2022 (version 3)

Copyright

© 2022, Kremer et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 945
    views
  • 220
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Philip HC Kremer
  2. Bart Ferwerda
  3. Hester J Bootsma
  4. Nienke Y Rots
  5. Alienke J Wijmenga-Monsuur
  6. Elisabeth AM Sanders
  7. Krzysztof Trzciński
  8. Anne L Wyllie
  9. Paul Turner
  10. Arie van der Ende
  11. Matthijs C Brouwer
  12. Stephen D Bentley
  13. Diederik van de Beek
  14. John Lees
(2022)
Pneumococcal genetic variability in age-dependent bacterial carriage
eLife 11:e69244.
https://doi.org/10.7554/eLife.69244

Share this article

https://doi.org/10.7554/eLife.69244

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Céline Petitgas, Laurent Seugnet ... Serge Birman
    Research Article

    Adenine phosphoribosyltransferase (APRT) and hypoxanthine-guanine phosphoribosyltransferase (HGPRT) are two structurally related enzymes involved in purine recycling in humans. Inherited mutations that suppress HGPRT activity are associated with Lesch–Nyhan disease (LND), a rare X-linked metabolic and neurological disorder in children, characterized by hyperuricemia, dystonia, and compulsive self-injury. To date, no treatment is available for these neurological defects and no animal model recapitulates all symptoms of LND patients. Here, we studied LND-related mechanisms in the fruit fly. By combining enzymatic assays and phylogenetic analysis, we confirm that no HGPRT activity is expressed in Drosophila melanogaster, making the APRT homolog (Aprt) the only purine-recycling enzyme in this organism. Whereas APRT deficiency does not trigger neurological defects in humans, we observed that Drosophila Aprt mutants show both metabolic and neurobehavioral disturbances, including increased uric acid levels, locomotor impairments, sleep alterations, seizure-like behavior, reduced lifespan, and reduction of adenosine signaling and content. Locomotor defects could be rescued by Aprt re-expression in neurons and reproduced by knocking down Aprt selectively in the protocerebral anterior medial (PAM) dopaminergic neurons, the mushroom bodies, or glia subsets. Ingestion of allopurinol rescued uric acid levels in Aprt-deficient mutants but not neurological defects, as is the case in LND patients, while feeding adenosine or N6-methyladenosine (m6A) during development fully rescued the epileptic behavior. Intriguingly, pan-neuronal expression of an LND-associated mutant form of human HGPRT (I42T), but not the wild-type enzyme, resulted in early locomotor defects and seizure in flies, similar to Aprt deficiency. Overall, our results suggest that Drosophila could be used in different ways to better understand LND and seek a cure for this dramatic disease.

    1. Genetics and Genomics
    Gbolahan Bamgbose, Guillaume Bordet ... Alexei Tulin
    Research Article

    PARP-1 is central to transcriptional regulation under both normal and stress conditions, with the governing mechanisms yet to be fully understood. Our biochemical and ChIP-seq-based analyses showed that PARP-1 binds specifically to active histone marks, particularly H4K20me1. We found that H4K20me1 plays a critical role in facilitating PARP-1 binding and the regulation of PARP-1-dependent loci during both development and heat shock stress. Here, we report that the sole H4K20 mono-methylase, pr-set7, and parp-1 Drosophila mutants undergo developmental arrest. RNA-seq analysis showed an absolute correlation between PR-SET7- and PARP-1-dependent loci expression, confirming co-regulation during developmental phases. PARP-1 and PR-SET7 are both essential for activating hsp70 and other heat shock genes during heat stress, with a notable increase of H4K20me1 at their gene body. Mutating pr-set7 disrupts monomethylation of H4K20 along heat shock loci and abolish PARP-1 binding there. These data strongly suggest that H4 monomethylation is a key triggering point in PARP-1 dependent processes in chromatin.